PNPLA3 and Hepatic fibrosis: Collectively, our findings uncover I148M PNPLA3 as an additional interesting contributor of impaired cholesterol and lipid metabolism in human HSCs, predisposing to exacerbated proinflammatory phenotype and enhanced hepatic fibrosis severity in humans.